GCG and type 1 diabetes mellitus: Future work should integrate quality‐of‐life metrics, examine cost‐effectiveness, and explore adjunctive therapies—such as mini‐dose glucagon or dual‐hormone systems—to refine safe fasting protocols for people with T1D across diverse cultural and socioeconomic contexts.